Brand Recall Hub

Lots Recalls in Canada

133 recalls found for Lots. Data sourced from Health Canada, CFIA, and Transport Canada. Updated daily.

133 Lots Recalls

Health Products Type II
2026-09-21

IMAAVY: Affected lots may contain glass particles

Product quality

View recall details →

Health Products Type III
2026-09-16

Platinum Naturals Easymulti Stress (men): Affected lots incorrectly labelled for Vitamin B6 quantity

Labelling

View recall details →

Other Type I
2026-08-15

Two lots of Teva-Pregabalin 150 mg capsules recalled due to cross-contamination with the drug sertraline

Contamination

View recall details →

Health Products Type II
2026-08-05

JAMP Methotrexate 10 mg Tablets: Affected lots may contain oversized tablets.

Product quality

View recall details →

Other Type I
2026-07-08

Two lots of Omnitrope injectable human growth hormone recalled due to cracked cartridges

Product quality

View recall details →

Health Products Type III
2026-03-31

Auro-Canagliflozin: Affected lots are labelled with the incorrect DIN found on the blister card.

Product safety

View recall details →

Health Products Type II
2026-03-17

Disinfectant Spray & Wipe Cleaner: Affected lots contain solution that do not meet the labelled strength

Product safety

View recall details →

Health Products Type II
2026-03-09

KETOROLAC: The weight is out of specification in the affected lots.

Product quality

View recall details →

Health Products Type II
2026-02-16

APO-CANDESARTAN: Affected lots were manufactured using an active ingredient that was out of specification for dissolution

Product quality

View recall details →

Health Products Type I
2026-02-09

MAR-AMLODIPINE: affected lots may contain tablet(s) of Midodrine 2.5mg tablets.

Product safety

View recall details →

Health Products Type III
2026-02-09

Cefazolin for Injection: Affected lots are packaged with the incorrect Linear barcode on inner and outer bag labels.

Labelling

View recall details →

Health Products Type II
2026-02-09

TARO-CANDESARTAN: Affected lots were manufactured using an active ingredient that was out of specification for dissolution

Product quality

View recall details →

Other
2026-02-07

Two lots of MAR-Amlodipine 5 mg tablets recalled as some bottles may contain the wrong drug

Product safety

View recall details →

Health Products Type II
2025-11-24

Extra Strength Ibuprofen Liquid Gel Capsules: Presence of cloudy capsules in affected lots

Product quality

View recall details →

Health Products Type II
2025-11-10

FOLLTROPIN-V : affected lots may contain particulate matter

Product quality

View recall details →

Health Products Type I
2025-07-16

Mylan-Cinacalcet: Affected lots exceed the established acceptable intake limit for N-nitroso-cinacalcet.

Product quality

View recall details →

Health Products Type II
2025-07-07

Anesketin : Presence of particulate matter in the affected lots

Product quality

View recall details →

Other
2025-06-17

Accel-Ondansetron ODT, Mint-Betahistine and PMS-Pirfenidone tablets recalled due to data integrity concerns

Product safety

View recall details →

Other
2025-06-04

Two lots of Seasonale birth control recalled due to extra placebo pills

Product quality

View recall details →

Health Products Type I
2025-04-29

RIVA-FLUOXETINE: Affected lots exceed the interim acceptable intake limit for N-nitroso-fluoxetine.

Product quality

View recall details →

Health Products Type I
2025-04-28

PMS-FLUOXETINE: Affected lots exceed the interim acceptable intake limit for N-nitroso-fluoxetine.

Product quality

View recall details →

Health Products Type I
2025-04-28

PRO-FLUOXETINE: Affected lots exceed the interim acceptable intake limit for N-nitroso-fluoxetine.

Product quality

View recall details →

Health Products
2025-04-22

JAMP Valproic Acid Oral Solution: Presence of large solid crystals in affected lots

Product quality

View recall details →

Other
2025-04-18

Three lots of JAMP Valproic Acid Oral Solution recalled

Product quality

View recall details →

Health Products Type II
2025-04-15

Life Brand Timed Release Melatonin 10mg: Some lots are labelled with incorrect dosing instructions.

Labelling

View recall details →

Health Products Type II
2025-04-11

NRA-Quetiapine XR: Some lots exceed the intake limit of N-nitroso-desalkyl-quetiapine (NDAQ)

Product quality

View recall details →

Health Products Type I
2025-01-07

QUETIAPINE XR : Affected lots may exceed the established acceptable intake limit for N-nitroso-desalkyl-quetiapine (NNAP)

Product quality

View recall details →

Health Products Type I
2024-12-30

PMS-CINACALCET: Affected lots may exceed the established acceptable intake limit for N-nitroso-cinacalcet.

Product safety

View recall details →

Health Products Type II
2024-12-20

TEVA-Codeine Tablets: out of specification on friability test (broken tablet) during stability testing for affected lots.

Product safety

View recall details →

Health Products Type I
2024-12-05

BETAHISTINE: Affected lots exceed or may exceed the interim acceptable intake limit for N-nitroso-betahistine.

Product safety

View recall details →

Showing 30 of 133 recalls. View all →